A. Comparison of survival among 60 subjects with sEGFR mutations with and without TP53 mutation.
B. Comparison of survival among 49 subjects with sEGFR mutations with a disruptive TP53 versus those without any TP53 mutation.
C. Comparison of survival among 83 subjects with sEGFR, ALKr, or ROS1r mutations with and without TP53 mutation.
D. Comparison of survival among 71 subjects with sEGFR, ALKr, or ROS1r mutations with a disruptive TP53 versus those without any TP53 mutation.